We are live on
!
Find out more
FLAM
First Light Asset Management Portfolio holdings
AUM
$1.65B
1-Year Est. Return
203.21%
This Fund
S&P 500
This Quarter
Est. Return
+17.63%
1 Year Est. Return
+203.21%
3 Year Est. Return
+364.25%
5 Year Est. Return
+595.91%
10 Year Est. Return
+10,683%
AUM
$232M
AUM Growth
+$16.4M
(+7.6%)
Cap. Flow
-$8.14M
Cap. Flow
% of AUM
-3.5%
Top 10 Holdings %
Top 10 Hldgs %
43.79%
Holding
71
New
6
Increased
12
Reduced
32
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SAGE
Sage Therapeutics
SAGE
|
+$3.83M |
| 2 |
SHPG
Shire pic
SHPG
|
+$3.82M |
| 3 |
HealthStream
HSTM
|
+$2.24M |
| 4 |
ARRY
Array Biopharma Inc
ARRY
|
+$1.67M |
| 5 |
Ionis Pharmaceuticals
IONS
|
+$1.59M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$4.87M |
| 2 |
LDRH
LDR HOLDINGS CORP COM STK
LDRH
|
+$3.91M |
| 3 |
LeMaitre Vascular
LMAT
|
+$3.55M |
| 4 |
BEAT
BioTelemetry, Inc.
BEAT
|
+$3.02M |
| 5 |
ENZ
Enzo Biochem, Inc.
ENZ
|
+$1.89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 90.76% |
| 2 | Energy | 3.54% |
| 3 | Miscellaneous | 2.27% |
| 4 | Communication Services | 1.89% |
| 5 | Real Estate | 1.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SHPG
26
DELISTED
Shire pic
SHPG
| $3.8M | 1.64% |
+19,598
| New | +$3.82M |
|
|
27
LeMaitre Vascular
LMAT
$1.84B
| $3.62M | 1.56% |
182,634
-202,928
| -53% | -$3.55M |
|
|
ELGX
28
DELISTED
Endologix Inc
ELGX
| $3.29M | 1.42% |
25,691
-152
| -0.6% | -$19.5K |
|
|
DOC
29
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $3.28M | 1.41% |
152,365
-3,484
| -2% | -$73.7K |
|
|
STRM
30
DELISTED
Streamline Health Solutions
STRM
| $3.24M | 1.39% |
117,353
-2,116
| -2% | -$47.6K |
|
|
IMMU
31
DELISTED
Immunomedics Inc
IMMU
| $3.23M | 1.39% |
992,867
+5,013
| +0.5% | +$14K |
|
|
CPHD
32
DELISTED
Cepheid Inc
CPHD
| $3.2M | 1.38% |
60,805
-1,373
| -2% | -$54.7K |
|
33
BioMarin Pharmaceuticals
BMRN
$12.5B
| $2.95M | 1.27% |
31,912
+13,397
| +72% | +$1.26M |
|
34
Alkermes
ALKS
$7.72B
| $2.85M | 1.23% |
60,680
-1,388
| -2% | -$66K |
|
35
Bio-Techne
TECH
$11.3B
| $2.6M | 1.12% |
94,952
-1,632
| -2% | -$44.8K |
|
|
TEAR
36
DELISTED
TearLab Corporation
TEAR
| $2.35M | 1.01% |
361,425
-14,618
| -4% | -$109K |
|
|
NSTG
37
DELISTED
NanoString Technologies, Inc.
NSTG
| $2.31M | 1% |
115,860
-2,687
| -2% | -$42.6K |
|
38
Vertex Pharmaceuticals
VRTX
$130B
| $2.03M | 0.88% |
23,310
-525
| -2% | -$49.6K |
|
|
SRGA
39
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $1.87M | 0.81% |
19,962
-12,946
| -39% | -$1.3M |
|
|
40
Ionis Pharmaceuticals
IONS
$7.85B
| $1.86M | 0.8% |
+50,782
| New | +$1.59M |
|
41
QuidelOrtho
QDEL
$729M
| $1.8M | 0.78% |
81,700
-1,998
| -2% | -$42.7K |
|
|
BEAT
42
DELISTED
BioTelemetry, Inc.
BEAT
| $1.76M | 0.76% |
94,993
-160,170
| -63% | -$3.02M |
|
43
Becton Dickinson
BDX
$50.6B
| $610K | 0.26% |
3,480
| – | – |
|
|
CEMI
44
DELISTED
Chembio diagnostics, Inc.
CEMI
| $577K | 0.25% |
+78,023
| New | +$562K |
|
45
State Street SPDR S&P Biotech ETF
XBI
$10.4B
| $503K | 0.22% |
+7,590
| New | +$470K |
|
46
Novartis
NVS
$263B
| $479K | 0.21% |
6,774
| – | – |
|
|
AGN
47
DELISTED
Allergan plc
AGN
| $469K | 0.2% |
2,035
| – | – |
|
48
Steris
STE
$20.5B
| $463K | 0.2% |
6,330
| – | – |
|
|
AVGR
49
DELISTED
Avinger, Inc. Common Stock
AVGR
| $461K | 0.2% |
+1
| New | +$661K |
|
50
Johnson & Johnson
JNJ
$644B
| $451K | 0.19% |
3,820
| – | – |
|
Similar funds
AAM
NPA
SOS
BCM
BFO
AAG
MCIL
TIM
First Light Asset Management's Q3 2016 Portfolio in Review
As of Q3 2016, First Light Asset Management held 71 positions worth $232M, up 7.6% from $216M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
First Light Asset Management withdrew a net $8.14M in Q3 2016, closing 3 positions and reducing 32 holdings. Its most notable exit was Envision Healthcare Holdings Inc, an estimated $4.87M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 91% of assets, up from 88% a quarter earlier, followed by Energy and Miscellaneous.
Against the trend, First Light Asset Management opened a new position in Sage Therapeutics worth $4.33M.
- First Light Asset Management's largest Q3 2016 buy was Sage Therapeutics: 94,037 shares worth $4.33M.
- First Light Asset Management added most to HealthStream in Q3 2016, an estimated $2.24M increase.
- First Light Asset Management's biggest Q3 2016 reduction was LeMaitre Vascular, cutting an estimated $3.55M.
- First Light Asset Management fully exited Envision Healthcare Holdings Inc in Q3 2016, selling an estimated $4.87M.
- First Light Asset Management's ten largest holdings make up 44% of its $232M portfolio in Q3 2016.
- First Light Asset Management opened 6 new positions and closed 3 in Q3 2016.
- First Light Asset Management's portfolio value rose 7.6% quarter-over-quarter to $232M.
Based on First Light Asset Management's 13F filing for Q3 2016, filed 15 Nov 2016.